News
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert ...
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...
FDA set to change requirements to get vaccines approved as RFK Jr continues to push skepticism about their use - New FDA ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
An FDA advisory committee is scheduled to meet to discuss the formula for the next COVID-19 vaccines after being sidelined ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results